First-In-Human (FIH) Study of W0180 as Single Agent and in Combination With Pembrolizumab in Adults With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT04564417 · TERMINATED
Trial details
- NCT number
- NCT04564417
- Sponsor
- Pierre Fabre Medicament
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-08
- Primary completion
- 2023-12-19
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.